Artson Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 7, 2025, 12:12 am

Competitors of Artson Engineering Ltd

All Competitor Stocks of Artson Engineering Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:25 am

Below is a detailed analysis of the quarterly data for Artson Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 44.74 Cr.. The value appears to be declining and may need further review. It has decreased from 51.26 Cr. (Mar 2025) to 44.74 Cr., marking a decrease of 6.52 Cr..
• For Expenses, as of Jun 2025, the value is 41.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 47.33 Cr. (Mar 2025) to 41.40 Cr., marking a decrease of 5.93 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.34 Cr.. The value appears to be declining and may need further review. It has decreased from 3.93 Cr. (Mar 2025) to 3.34 Cr., marking a decrease of 0.59 Cr..
• For OPM %, as of Jun 2025, the value is 7.47%. The value appears to be declining and may need further review. It has decreased from 7.67% (Mar 2025) to 7.47%, marking a decrease of 0.20%.
• For Other Income, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.07 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.06 Cr..
• For Interest, as of Jun 2025, the value is 2.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.65 Cr. (Mar 2025) to 2.31 Cr., marking a decrease of 0.34 Cr..
• For Depreciation, as of Jun 2025, the value is 0.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.55 Cr. (Mar 2025) to 0.57 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.47 Cr.. The value appears to be declining and may need further review. It has decreased from 0.80 Cr. (Mar 2025) to 0.47 Cr., marking a decrease of 0.33 Cr..
• For Tax %, as of Jun 2025, the value is 53.19%. The value appears to be increasing, which may not be favorable. It has increased from 23.75% (Mar 2025) to 53.19%, marking an increase of 29.44%.
• For Net Profit, as of Jun 2025, the value is 0.22 Cr.. The value appears to be declining and may need further review. It has decreased from 0.60 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 0.38 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.06. The value appears to be declining and may need further review. It has decreased from 0.16 (Mar 2025) to 0.06, marking a decrease of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:25 am

Growth

Last Updated: September 5, 2025, 2:21 pm

Balance Sheet

Last Updated: October 10, 2025, 3:29 pm

Below is a detailed analysis of the balance sheet data for Artson Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 4.00 Cr..
• For Borrowings, as of Mar 2025, the value is 49.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 64.00 Cr. (Mar 2024) to 49.00 Cr., marking a decrease of 15.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 121.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86.00 Cr. (Mar 2024) to 121.00 Cr., marking an increase of 35.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 175.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 151.00 Cr. (Mar 2024) to 175.00 Cr., marking an increase of 24.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 161.00 Cr.. The value appears strong and on an upward trend. It has increased from 134.00 Cr. (Mar 2024) to 161.00 Cr., marking an increase of 27.00 Cr..
• For Total Assets, as of Mar 2025, the value is 175.00 Cr.. The value appears strong and on an upward trend. It has increased from 151.00 Cr. (Mar 2024) to 175.00 Cr., marking an increase of 24.00 Cr..

However, the Borrowings (49.00 Cr.) are higher than the Reserves (1.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Artson Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 1.64. This value is below the healthy minimum of 5. It has increased from -6.37 (Mar 23) to 1.64, marking an increase of 8.01.
• For Diluted EPS (Rs.), as of Mar 24, the value is 1.64. This value is below the healthy minimum of 5. It has increased from -6.37 (Mar 23) to 1.64, marking an increase of 8.01.
• For Cash EPS (Rs.), as of Mar 24, the value is 2.19. This value is below the healthy minimum of 3. It has increased from -6.04 (Mar 23) to 2.19, marking an increase of 8.23.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -17.85. It has increased from -19.50 (Mar 23) to -17.85, marking an increase of 1.65.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -17.85. It has increased from -19.50 (Mar 23) to -17.85, marking an increase of 1.65.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 34.70. It has decreased from 35.59 (Mar 23) to 34.70, marking a decrease of 0.89.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 3.97. This value is within the healthy range. It has increased from -2.60 (Mar 23) to 3.97, marking an increase of 6.57.
• For PBIT / Share (Rs.), as of Mar 24, the value is 3.41. This value is within the healthy range. It has increased from -2.93 (Mar 23) to 3.41, marking an increase of 6.34.
• For PBT / Share (Rs.), as of Mar 24, the value is 0.62. This value is within the healthy range. It has increased from -5.68 (Mar 23) to 0.62, marking an increase of 6.30.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 1.64. This value is below the healthy minimum of 2. It has increased from -6.37 (Mar 23) to 1.64, marking an increase of 8.01.
• For PBDIT Margin (%), as of Mar 24, the value is 11.42. This value is within the healthy range. It has increased from -7.29 (Mar 23) to 11.42, marking an increase of 18.71.
• For PBIT Margin (%), as of Mar 24, the value is 9.83. This value is below the healthy minimum of 10. It has increased from -8.21 (Mar 23) to 9.83, marking an increase of 18.04.
• For PBT Margin (%), as of Mar 24, the value is 1.79. This value is below the healthy minimum of 10. It has increased from -15.95 (Mar 23) to 1.79, marking an increase of 17.74.
• For Net Profit Margin (%), as of Mar 24, the value is 4.72. This value is below the healthy minimum of 5. It has increased from -17.88 (Mar 23) to 4.72, marking an increase of 22.60.
• For Return on Networth / Equity (%), as of Mar 24, the value is -9.18. This value is below the healthy minimum of 15. It has decreased from 0.00 (Mar 23) to -9.18, marking a decrease of 9.18.
• For Return on Capital Employeed (%), as of Mar 24, the value is 57.86. This value is within the healthy range. It has increased from -151.92 (Mar 23) to 57.86, marking an increase of 209.78.
• For Return On Assets (%), as of Mar 24, the value is 4.00. This value is below the healthy minimum of 5. It has increased from -15.06 (Mar 23) to 4.00, marking an increase of 19.06.
• For Long Term Debt / Equity (X), as of Mar 24, the value is -0.18. This value is below the healthy minimum of 0.2. It has increased from -0.22 (Mar 23) to -0.18, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 24, the value is -0.91. This value is within the healthy range. It has decreased from -0.81 (Mar 23) to -0.91, marking a decrease of 0.10.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has decreased from 0.88 (Mar 23) to 0.83, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1.5. It has increased from 0.88 (Mar 23) to 0.95, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 24, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 23) to 0.76, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.78. This value is below the healthy minimum of 4. It has decreased from 2.89 (Mar 23) to 1.78, marking a decrease of 1.11.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 1.42. This value is below the healthy minimum of 3. It has increased from -0.94 (Mar 23) to 1.42, marking an increase of 2.36.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.59. This value is below the healthy minimum of 3. It has increased from -1.31 (Mar 23) to 1.59, marking an increase of 2.90.
• For Enterprise Value (Cr.), as of Mar 24, the value is 577.58. It has increased from 306.34 (Mar 23) to 577.58, marking an increase of 271.24.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.51. This value exceeds the healthy maximum of 3. It has increased from 2.33 (Mar 23) to 4.51, marking an increase of 2.18.
• For EV / EBITDA (X), as of Mar 24, the value is 39.45. This value exceeds the healthy maximum of 15. It has increased from -31.95 (Mar 23) to 39.45, marking an increase of 71.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.04. This value exceeds the healthy maximum of 3. It has increased from 1.90 (Mar 23) to 4.04, marking an increase of 2.14.
• For Price / BV (X), as of Mar 24, the value is -7.85. This value is below the healthy minimum of 1. It has decreased from -3.46 (Mar 23) to -7.85, marking a decrease of 4.39.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.04. This value exceeds the healthy maximum of 3. It has increased from 1.90 (Mar 23) to 4.04, marking an increase of 2.14.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.09 (Mar 23) to 0.01, marking an increase of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness